check_circleStudy Completed

Vaginal yeast infections

Bayer Identifier:

Trial_0475

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Activity and tolerability of BAY b 5097 500mg vaginal tablets in single dose or one day treatment of vaginal Candida infections

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

N/A
  • -

  • -

Trial summary

Enrollment Goal
100
Trial Dates
January 1981 - May 1981
Phase
N/A
Could I Receive a placebo
N/A
Products
Mycelex (Clotrimazole, BAYB5097)
Accepts Healthy Volunteer
N/A

Trial design

Open label, mycologically controlled study to test the activity and tolerability of BAY b 5097 500mg vaginal tablets in single dose or one day treatment of vaginal Candida infections
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.